3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma

Status Completed

Clinical Trial Summary

Verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS.

Clinical Trial Description

The main purpose of the study was to verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS. A total of 100 patients were enrolled. The primary endpoint of the study was the objective response rate (ORR), and the secondary endpoint was the local control rate and the incidence of treatment-related side effects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03791944
Study type	Interventional
Source	Xinqiao Hospital of Chongqing
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2018
Completion date	May 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03212742` - Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients	Phase 1/Phase 2
Recruiting	`NCT06190782` - Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor	Phase 3
Recruiting	`NCT06120127` - Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Phase 2
Recruiting	`NCT05176002` - Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.	Phase 1/Phase 2
Not yet recruiting	`NCT05909137` - Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Recruiting	`NCT02661152` - DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.	Phase 3
Withdrawn	`NCT02542137` - Abscopal Effect for Metastatic Small Cell Lung Cancer	Phase 2
Completed	`NCT01212731` - Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Completed	`NCT01168479` - FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer	Phase 3
Recruiting	`NCT03658343` - T2* MRI Analysis for Sarcoma	N/A
Completed	`NCT03280719` - Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions	N/A
Recruiting	`NCT05515796` - Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors	Phase 2
Recruiting	`NCT05514327` - A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL	N/A
Recruiting	`NCT04453826` - Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma	Phase 3
Recruiting	`NCT03370926` - FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy	N/A
Active, not recruiting	`NCT03870919` - Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients	N/A
Active, not recruiting	`NCT02428049` - Radiation Pneumonitis After SBRT for NSCLC
Recruiting	`NCT04923620` - Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Active, not recruiting	`NCT05371795` - Comparison on Radiotherapy Permanent Skin Marking With Lancets and an Electric Marking Device	N/A
Recruiting	`NCT03210428` - Quantitative MR Imaging in Locally Advanced Cervical Cancer